BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mathonnet M, Descottes B, Valleix D, Truffinet V, Labrousse F, Denizot Y. Platelet-activating factor in cirrhotic liver and hepatocellular carcinoma. World J Gastroenterol 2006; 12(17): 2773-2778 [PMID: 16718768 DOI: 10.3748/wjg.v12.i17.2773]
URL: https://www.wjgnet.com/1007-9327/full/v12/i17/2773.htm
Number Citing Articles
1
Shuangfeng Yang, Yuan-Liang Wang, Yanping Lyu, Yu Jiang, Jianjun Xiang, Shumi Ji, Shuling Kang, Xuejie Lyu, Chenzhou He, Peixin Li, Baoying Liu, Chuancheng Wu. mGWAS identification of six novel single nucleotide polymorphism loci with strong correlation to gastric cancerCancer & Metabolism 2021; 9(1) doi: 10.1186/s40170-021-00269-2
2
Y. Denizot, R. De Armas, F. Caire, I. Pommepuy, V. Truffinet, F. Labrousse. Platelet‐activating factor and human meningiomasNeuropathology and Applied Neurobiology 2006; 32(6): 674 doi: 10.1111/j.1365-2990.2006.00775.x
3
Ali Salajegheh. Angiogenesis in Health, Disease and Malignancy2016; : 253 doi: 10.1007/978-3-319-28140-7_39
4
Meng Zhang, Ya-Ping Li, Na He, Shuang-Suo Dang. Platelets in liver cancerWorld Chinese Journal of Digestology 2024; 32(10): 735 doi: 10.11569/wcjd.v32.i10.735
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
5
A. R. Rama, A. Aguilera, C. Melguizo, O. Caba, J. Prados. Tissue Specific Promoters in Colorectal CancerDisease Markers 2015; 2015: 1 doi: 10.1155/2015/390161
6
Eleonora Stanca, Gaetano Serviddio, Francesco Bellanti, Gianluigi Vendemiale, Luisa Siculella, Anna Maria Giudetti. Down-regulation of LPCAT expression increases platelet-activating factor level in cirrhotic rat liver: Potential antiinflammatory effect of silybinBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013; 1832(12): 2019 doi: 10.1016/j.bbadis.2013.07.005
7
Linna Cao, Yiwei Zhang, Jinxia Mi, Zhanhao Shi, Zhaoqin Fang, Dongwei Jia, Zhiqiang Pan, Peike Peng. α-Hederin inhibits the platelet activating factor-induced metastasis of HCC cells through disruption of PAF/PTAFR axis cascaded STAT3/MMP-2 expressionPharmacological Research 2022; 178: 106180 doi: 10.1016/j.phrs.2022.106180
8
Kieran F. Scott, Mila Sajinovic, Juliane Hein, Sheri Nixdorf, Peter Galettis, Winston Liauw, Paul de Souza, Qihan Dong, Garry G. Graham, Pamela J. Russell. Emerging roles for phospholipase A2 enzymes in cancerBiochimie 2010; 92(6): 601 doi: 10.1016/j.biochi.2010.03.019
9
Tomomi Shida-Sakazume, Yosuke Endo-Sakamoto, Motoharu Unozawa, Chonji Fukumoto, Ken Shimada, Atsushi Kasamatsu, Katsunori Ogawara, Hidetaka Yokoe, Masashi Shiiba, Hideki Tanzawa, Katsuhiro Uzawa, Chih-Hsin Tang. Lysophosphatidylcholine Acyltransferase1 Overexpression Promotes Oral Squamous Cell Carcinoma Progression via Enhanced Biosynthesis of Platelet-Activating FactorPLOS ONE 2015; 10(3): e0120143 doi: 10.1371/journal.pone.0120143
10
Sindhia Kumari, Arslan Ali, Talat Roome, Anam Razzak, Ayesha Iqbal, Amna Jabbar Siddiqui, Syed Muhammad Zahid Azam, Hafeezullah Shaikh, Hesham R. El-Seedi, Syed Ghulam Musharraf. Metabolomics approach to understand the hepatitis C virus induced hepatocellular carcinoma using LC-ESI-MS/MSArabian Journal of Chemistry 2021; 14(1): 102907 doi: 10.1016/j.arabjc.2020.11.013
11
Ronan Lordan, Alexandros Tsoupras, Ioannis Zabetakis. The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and TreatmentAdvances in Nutrition 2019; 10(1): 148 doi: 10.1093/advances/nmy090
12
Dandan Meng, Meng Ren, Maofeng Li, Min Wang, Wei Geng, Qingxin Shang. Molecular mechanism of α-Hederin in tumor progressionBiomedicine & Pharmacotherapy 2024; 170: 116097 doi: 10.1016/j.biopha.2023.116097
13
Jingting Jiang, Changping Wu, Guanghua Luo, Lu Zheng, Lujun Chen, Xiaoying Zhang, Ning Xu. Expression of apolipoprotein M in human hepatocellular carcinoma tissuesActa Histochemica 2011; 113(1): 53 doi: 10.1016/j.acthis.2009.08.005
14
Kandahalli Venkataranganayaka Abhilasha, Mosale Seetharam Sumanth, Vyala Hanumanthareddy Chaithra, Shancy Petsel Jacob, Anita Thyagarajan, Ravi Prakash Sahu, Rajesh Rajaiah, K. Sandeep Prabhu, Kempaiah Kemparaju, Jeffrey Bryant Travers, Chu-Huang Chen, Gopal Kedihithlu Marathe. p38 MAP-kinase inhibitor protects against platelet-activating factor-induced death in miceFree Radical Biology and Medicine 2019; 143: 275 doi: 10.1016/j.freeradbiomed.2019.08.019
15
Hua Zhao, Yulan Cheng, Andrew Kalra, Ke Ma, Yueyuan Zheng, Benjamin Ziman, Caitlin Tressler, Kristine Glunde, Eun Ji Shin, Saowanee Ngamruengphong, Mouen Khashab, Vikesh Singh, Robert A. Anders, Simran Jit, Nicolas Wyhs, Wei Chen, Xu Li, De-Chen Lin, Stephen J. Meltzer. Generation and multiomic profiling of aTP53/CDKN2Adouble-knockout gastroesophageal junction organoid modelScience Translational Medicine 2022; 14(673) doi: 10.1126/scitranslmed.abq6146
16
Ronan Lordan, Alexandros Tsoupras, Ioannis Zabetakis, Constantinos A. Demopoulos. Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research PerspectivesMolecules 2019; 24(23): 4414 doi: 10.3390/molecules24234414
17
Vladislava Melnikova, Menashe Bar-Eli. Inflammation and melanoma growth and metastasis: The role of platelet-activating factor (PAF) and its receptorCancer and Metastasis Reviews 2007; 26(3-4): 359 doi: 10.1007/s10555-007-9092-9